Ana Isabel Tergas, MD, MPH
Assistant Professor
NYP/Columbia University Medical Center
630 W 168th St
New York,
NY
USA
10032
Papers:
43
Identification of potential therapeutic targets by molecular profiling of 628 cases of uterine serous carcinoma
64
High versus low-dose rate brachytherapy for locally advanced cervical cancer
92
Ovarian cancer patients selected for neoadjuvant chemotherapy vs. primary debulking surgery are not similar: a National Cancer Data Base study
115
Sexual and marital dysfunction in women with gynecologic cancer: results of a multi-institutional, cross-sectional trial
119
Measurement and validation of frailty as a predictor of outcomes in women undergoing major gynecologic surgery
141
Molecular characterization of 361 cases of uterine carcinosarcomas reveal alterations in the DNA repair and PI3K pathways as potential therapeutic targets
229
Population-level survival trends for uterine cancer
240
Identifying potential therapeutics by molecular profiling of 136 cases of uterine clear cell carcinoma
275
Secular trends in relative survival for ovarian cancer
300
A systematic review of radiotherapy resources in low and middle income countries
383
Distinct molecular landscapes between endometrioid and non-endometrioid uterine carcinoma
436
Risk stratification and outcomes of women undergoing surgery for ovarian cancer
463
Refusal of recommend chemotherapy for ovarian cancer: risk factors and outcomes, a National Cancer Database study
476
Real world effectiveness of minimally invasive hysterectomy for uterine cancer
Robot-assisted radical trachelectomy: surgical techniques
Transition into the next phase